Xialu S, Faqiang M
Discov Oncol. 2025; 16(1):303.
PMID: 40072772
PMC: 11903988.
DOI: 10.1007/s12672-025-02035-y.
Park M, Jung J, Lee J, Lee E, Lee H, Eom H
Ann Hematol. 2025; .
PMID: 40069438
DOI: 10.1007/s00277-025-06293-2.
Sun J, Song S, Liu J, Chen F, Li X, Wu G
NPJ Biofilms Microbiomes. 2025; 11(1):43.
PMID: 40069181
PMC: 11897378.
DOI: 10.1038/s41522-025-00678-x.
Li D, Lan X, Xu L, Zhou S, Luo H, Zhang X
Front Immunol. 2025; 16:1552010.
PMID: 40066456
PMC: 11891355.
DOI: 10.3389/fimmu.2025.1552010.
Wei Y, Qin L, Wu X, Li D, Qian D, Jiang H
BMJ Open. 2025; 15(3):e094366.
PMID: 40037667
PMC: 11881178.
DOI: 10.1136/bmjopen-2024-094366.
The Relationship Between Gut Microbiome Bifidobacterium and Anti-tumor Immune Responses in Esophageal Squamous Cell Carcinoma.
Wang H, Baba Y, Hara Y, Toihata T, Kosumi K, Harada K
Ann Surg Oncol. 2025; .
PMID: 40035906
DOI: 10.1245/s10434-024-16288-4.
Gut-X axis.
Lin X, Yu Z, Liu Y, Li C, Hu H, Hu J
Imeta. 2025; 4(1):e270.
PMID: 40027477
PMC: 11865426.
DOI: 10.1002/imt2.270.
Intestinal Probiotic Lysate Modified Bifunctional Nanoparticle for Efficient Colon Cancer Immunotherapy.
Zhu M, Chen H, Chen X, Zhang Y, Chen X, Zhou B
Pharmaceutics. 2025; 17(2).
PMID: 40006507
PMC: 11859493.
DOI: 10.3390/pharmaceutics17020139.
Leveraging Microorganisms to Combat Skin Cancer.
Oyler H, Callister A, Kutch M, Wakefield M, Fang Y
Microorganisms. 2025; 13(2).
PMID: 40005824
PMC: 11858759.
DOI: 10.3390/microorganisms13020462.
HPV Infection and Oral Microbiota: Interactions and Future Implications.
Xia Q, Pierson S
Int J Mol Sci. 2025; 26(4).
PMID: 40003891
PMC: 11855562.
DOI: 10.3390/ijms26041424.
Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It.
Zielinska M, Ciazynska M, Sulejczak D, Rutkowski P, Czarnecka A
Biomolecules. 2025; 15(2).
PMID: 40001572
PMC: 11853485.
DOI: 10.3390/biom15020269.
Association between antibiotics and treatment efficacy in metastatic urothelial carcinoma patients.
Braun A, Deng M, Hasler J, Bukavina L, Handorf E, Abbosh P
BMC Med. 2025; 23(1):117.
PMID: 40001066
PMC: 11863714.
DOI: 10.1186/s12916-024-03786-1.
Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria.
Lu D, Ma X, Tao K, Lei H
Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996827
PMC: 11853859.
DOI: 10.3390/cimb47020106.
Correlation between gut microbiota and tumor immune microenvironment: A bibliometric and visualized study.
Hu Z, Zhu H, Jin Y, Liu P, Yu X, Zhang Y
World J Clin Oncol. 2025; 16(2):101611.
PMID: 39995564
PMC: 11686564.
DOI: 10.5306/wjco.v16.i2.101611.
Inflammation in cancer: therapeutic opportunities from new insights.
Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q
Mol Cancer. 2025; 24(1):51.
PMID: 39994787
PMC: 11849313.
DOI: 10.1186/s12943-025-02243-8.
[Intestinal Flora Dysregulation and Lung Cancer:
Mechanism Analysis and Clinical Application].
Chen L, Xie Y, Li C
Zhongguo Fei Ai Za Zhi. 2025; 28(1):69-74.
PMID: 39988442
PMC: 11848647.
DOI: 10.3779/j.issn.1009-3419.2025.106.02.
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.
Talpin A, Maia A, Carpier J, Kulakowski G, Aubergeon L, Kervevan J
J Immunother Cancer. 2025; 13(2).
PMID: 39979071
PMC: 11842988.
DOI: 10.1136/jitc-2024-010192.
Health benefits, antimicrobial activities, and potential applications of probiotics: A review.
Sepehr A, Miri S, Aghamohammad S, Rahimirad N, Milani M, Pourshafie M
Medicine (Baltimore). 2025; 103(52):e32412.
PMID: 39969286
PMC: 11688011.
DOI: 10.1097/MD.0000000000032412.
Microbiota does not influence tumor development in two models of heritable cancer.
Spring J, Gurbuxani S, Golovkina T
mBio. 2025; 16(3):e0386624.
PMID: 39969175
PMC: 11898629.
DOI: 10.1128/mbio.03866-24.
Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis.
Giakomidi D, Ishola A, Nus M
Front Cardiovasc Med. 2025; 12:1502124.
PMID: 39957996
PMC: 11825770.
DOI: 10.3389/fcvm.2025.1502124.